(Q38056813)

27 August 2017

title

Metabonomic analysis of HIV-infected biofluids (English)

1 reference

27 August 2017

Lungile J Sitole

1

1 reference

27 August 2017

Aurelia A Williams

series ordinal

2

1 reference

27 August 2017

Debra Meyer

series ordinal

3

1 reference

27 August 2017

publication date

1 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

18-28

1 reference

Increased resting energy expenditure in human immunodeficiency virus-infected men.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Biomarkers for neuroAIDS: the widening scope of metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic complications associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

HMDB: the Human Metabolome Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic disorders and chronic viral disease: the case of HIV and HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

The experts speak. Metabolic complications associated with HIV infection and antiretroviral therapy. Interview by Vicki Glaser.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

The metabolic puzzle during the evolution of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Factors Associated With Mitochondrial Dysfunction in Circulating Peripheral Blood Lymphocytes From HIV-Infected People

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Mitochondrial damage in adipose tissue of untreated HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Insulin resistance in treated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

HIV-associated lipodystrophy: from fat injury to premature aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

The effect of protease inhibitors on weight and body composition in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Dynamics of the cellular metabolome during human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Weight loss and wasting in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Comparative 1H NMR-based metabonomic analysis of HIV-1 sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Antiretroviral therapy is associated with an atherogenic lipoprotein phenotype among HIV-1-infected men in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Spectroscopy in Medically-Underserved HIV-Infected Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

CSF proteomic fingerprints for HIV-associated cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Short communication: quantitative proteomic plasma profiling reveals activation of host defense to oxidative stress in chronic SIV and methamphetamine comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Simple rapid method for quantification of antiretrovirals by liquid chromatography-tandem mass-spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Quantitative acylcarnitine profiling in peripheral blood mononuclear cells using in vitro loading with palmitic and 2-oxoadipic acids: biochemical confirmation of fatty acid oxidation and organic acid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Theoretical studies on the regulation of oxidative phosphorylation in intact tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MB25318F

21 January 2018

Identifiers

DOI

10.1039/C2MB25318F

1 reference

27 August 2017

1 reference